Post-COVID hair loss: four biological pathways, one clinical picture — and why the long COVID variant is a different problem from the acute infection one.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
0:00
|
6:50
From Root to Ritual by Laritelle Organic.
In brief: Post-COVID hair loss is one of the most common and most distressing long-term effects of COVID-19 infection — yet it remains under-discussed in mainstream health communication. A 2024 multi-centre cross-sectional study of 500 female COVID patients found 61.4% experienced hair problems after infection, with telogen effluvium accounting for the majority. A May 2026 review identified four d...
Read the full article: https://laritelleorganic.com/blogs/from-root-to-ritual/post-covid-hair-loss-four-biological-pathways-one-clinical-picture-and-why-the-long-covid-variant-is-a-different-problem-from-the-acute-infection-one
SPEAKER_00
In brief, post-COVID hair loss is one of the most common and most distressing long-term effects of COVID-19 infection, yet it remains under discussed in mainstream health communication. A 2024 multi-center cross-sectional study of 500 female COVID patients found 61.4% experienced hair problems after infection, with telogenifluvium accounting for the majority. A May 2026 review identified four distinct biological pathways. Most post-acute COVID hair loss resolves within six and nine months without specific hair treatment. Long COVID-associated persistent hair loss beyond nine, twelve months is a different, more complex problem that requires a different assessment approach. As of 2026, although the acute phase of the pandemic is behind us, post-COVID hair loss continues to be seen both as part of the long COVID syndrome and in people infected with new variants. Thousands of people are searching for the link between long COVID and hair loss. The question this article addresses is not just, does COVID cause hair loss? That is now well established, but rather, what are the specific biological mechanisms, what determines whether someone experiences it, how long it lasts, and what is actually different about long COVID-associated hair loss versus the acute post-COVID shedding wave. How common is post-COVID hair loss? The data is consistent across studies. A survey by the Indiana University School of Medicine found almost 27% of people experience hair shedding after a COVID infection. A 202, to systematic review found hair loss affected between 20 to 25% of COVID-19 survivors. The 2024 Multi-Center Study, the largest female-specific data set, found a substantially higher rate in women. A 2024 multi-center cross-sectional study of 500 female COVID-19 patients found that 61.4% experienced some form of hair problem after infection, with telogenifluvium accounting for the majority of cases. Among the 307 women who reported hair problems, the breakdown included diffuse shedding, overall thinning, and textural changes. Risk factors identified in the same study included older age, more severe initial COVID illness, and nutritional deficiency during recovery. The gender difference in these figures, 27% overall versus 61.4% in women specifically, is consistent with what is known about women's greater susceptibility to telogen effluvium in general. The interaction between physiological stress, iron status, thyroid function, and hormonal context means women's hair follicles are more reactive to systemic stressors than men's. What are the four biological pathways through which COVID causes hair loss? A comprehensive review published by the COVID-19 Longhaul Foundation in May 2026 synthesized current evidence on the pathophysiology of COVID-associated hair disorders. Four distinct pathways were identified. Pathway 1, cytokine storm, and inflammatory follicle disruption. The most likely cause of post-COVID hair loss is an excessive release of pro-inflammatory cytokines during SARS-CoV-2 infection. This process can trigger the development of telogen effluvium by damaging hair matrix cells. The cytokine profile of COVID-19, elevated IL-6, TNFA, Illinois, 1B, pushes large numbers of anagin follicles simultaneously into catogen and then telegen, producing the diffuse shedding wave that arrives two, three months later. This is the same mechanism as any other physiological stress trigger, surgery, severe illness, crash diet, amplified by the scale of the COVID-19 cytokine response. Pathway 2, vascular injury to follicle blood supply. COVID-19 causes direct damage to endothelial cells of small vessels, and indirect damage through the release of cytokines and development of immune inflammation around hair follicles, as well as activation of the coagulation cascade, which leads to thrombus formation in vessels supplying hair follicles, resulting in ischemia and necrosis of follicles. COVID-19's well-documented vascular pathology, endothelial dysfunction, microthrombi, extends to the scalp's microvascular supply. Follicles deprived of adequate blood supply during the acute illness may undergo premature entry into telogen, or in severe cases, direct follicle damage. This vascular pathway may explain why more severe COVID illness correlates with more severe and prolonged hair loss. Pathway 3. Hypoxic stress from respiratory illness. Hair follicle dysfunction appears to result from a convergence of systemic inflammation, cytokine-mediated follicular cycling diser, uption, hypoxic stress, and metabolic reprogramming of keratinocytes. Hair matrix cells are among the most rapidly dividing cells in the body. They require substantial oxygen delivery. COVID-19's respiratory effects, including reduced oxygen saturation during illness, create hypoxic stress in actively growing follicles that disrupts energy metabolism and keratinocyte function. The hair shaft quality changes, texture alterations, changes in curl pattern that some COVID patients report alongside shedding reflect this metabolic disruption at the hair matrix level during active illness. Pathway 4. Immune privilege collapse at the hair bulb. Emerging molecular studies suggest potential direct viral interaction with follicular epithelial structures and immune privilege collapse within the hair bulb microenvironment. The follicle's immune privilege, the mechanism by which the follicle normally protects itself from immune attack, may be disrupted by the systemic immune dysregulation of COVID-19. A 2025 study, Klingenstein et al. detected SARS-CoV-2 spike protein in hair follicles, suggesting possible direct viral interaction with follicular tissue. This pathway is less established than the cytokine and vascular mechanisms, but may explain why some COVID patients develop new onset alopecia ariata following infection, immune privilege collapse in susceptible individuals. 61.4% of 500 female COVID patients experienced hair problems post infection, 2024 Multicenter S.